Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 0904-6801

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 0904-6801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 00

This is a description of a medication called Quetiapine extended-release tablets. It comes in a unit dose package containing 100 tablets. Each coated tablet contains 481 mg of Quetiapine fumarate USP, equivalent to 460 mg Quetiapine. The medication should be swallowed whole, without crushing or chewing. Dosage should be taken only once a day according to the product information provided. Storage should be at 25°C. The medication guide can be found at the manufacturer's website. The text also includes dosage instructions and warnings.*

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 01

This is a description of a medication called Quetiapine Extended-Release Tablets USP, with an NDC of 0904-6804-61, packaged in unit dose. The medication guide needs to be dispensed along with the 100 tablets. The medication may be taken once daily, with a dosage of either 50 mg, 150 mg, 200 mg, 300 mg, or 400 mg. The medication should be stored at a temperature of 25°C (77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The package should be kept out of reach of children and is only intended for use by adults. The medication is distributed by Mrs. J.M. Mackellar's, and further information can be found at MajorPharmaceuticals.com.*

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 02

This is a medication guide for Quetiapine Extended-Release Tablets USP. The package contains 100 tablets with each coated tablet containing 230 mg of Quetiapine Fumarate USP equivalent to 200 mg Quetiapine. It is advised to swallow the tablet whole and not to crush or chew it. The usual dosage is once a day. Complete prescribing information can be found in the medication guide available at wanmairpharmaceuticals.com. It should be stored at a temperature below 25°C and away from moisture. The package should be kept out of reach of children and only intended for the intended use.*

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 03

This is a description of a medication called Quetiapine Extended-Release Tablets USP. It comes in a unit dose of 100 tablets with each tablet containing 1731mg of quetiapine hemifumarate USP equivalent to 100mg of quetiapine. The recommended dosage is once daily, and it is important to read the medication guide provided by the pharmacist. The product contains warnings and storage instructions and should be kept out of reach of children. The text also includes the NDC numbers for the medication produced by Major Pharmaceuticals.*

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 04

This is a description of a medication called Quetiapine in extended-release form. The medication is available in tablet form and one pack contains 100 tablets. The drug is not available over the counter and should only be dispensed with a medication guide by a licensed pharmacist. The storage temperature is recommended at room temperature, and the medication is manufactured by a company called Major. Finally, some additional information in the text could not be deciphered.*

FDA Label Image

E3429a09 4870 4e48 9a35 512236e39832 01

FDA Label Image

E3429a09 4870 4e48 9a35 512236e39832 02

The text describes a figure showing Kaplan-Meier curves depicting the time to relapse in patients with schizophrenia in Study 3. The x-axis represents time in months, and the y-axis shows the proportion of patients with relapse in percentage. The figure includes curves for two treatment groups: Placebo and Quetiapine, and an extended-release group. The results displayed in the figure are from an interim analysis.*

FDA Label Image

E3429a09 4870 4e48 9a35 512236e39832 03

Figure 2 displays the Kaplan-Meier curves illustrating the time it took for the recurrence of a mood episode to occur. The graph represents data from Study 9, where 100 patients were monitored over a certain period. The proportion of patients experiencing a relapse is plotted against time (in weeks) on the x-axis. Unfortunately, some non-English characters and errors are present, which may not affect the interpretation of the figure.*

FDA Label Image

E3429a09 4870 4e48 9a35 512236e39832 04

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.